Literature DB >> 9243769

The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection.

S Kleinman1, M P Busch, J J Korelitz, G B Schreiber.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9243769     DOI： 10.1053/tmrv.1997.0110155

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN： 0887-7963


× No keyword cloud information.
  25 in total

1.  Blood screening by nucleic acid amplification technology: current issues, future challenges.

Authors:  J L Gallarda; E Dragon
Journal:  Mol Diagn       Date:  2000-03

2.  Safety in transfusion medicine.

Authors:  Giuseppe Aprili
Journal:  Blood Transfus       Date:  2008-07       Impact factor: 3.443

3.  Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.

Authors:  Mars Stone; John Bainbridge; Ana M Sanchez; Sheila M Keating; Andrea Pappas; Wes Rountree; Chris Todd; Sonia Bakkour; Mark Manak; Sheila A Peel; Robert W Coombs; Eric M Ramos; M Kathleen Shriver; Paul Contestable; Sangeetha Vijaysri Nair; David H Wilson; Martin Stengelin; Gary Murphy; Indira Hewlett; Thomas N Denny; Michael P Busch
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

4.  Blood donor deferral policies across Europe and characteristics of men whohave sex with men screened for human immunodeficiency virus in bloodestablishments: data from the European Men-who-have-sex-with-men Internet Survey (EMIS).

Authors:  Susanne B Schink; Ruth Offergeld; Axel J Schmidt; Ulrich Marcus
Journal:  Blood Transfus       Date:  2017-03-23       Impact factor: 3.443

5.  Multicenter evaluation of a semiautomated, standardized assay for detection of hepatitis B virus DNA in blood donations.

Authors:  Luisa Romanò; Claudio Velati; Lorella Baruffi; Laura Fomiatti; Giuseppe Colucci; Alessandro R Zanetti
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

6.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Authors:  Steven Kleinman; Melissa R King; Michael P Busch; Edward L Murphy; Simone A Glynn
Journal:  Transfus Med Rev       Date:  2012-05-24

7.  Prevalence and incidence of bloodborne viral infections among Danish prisoners.

Authors:  P B Christensen; H B Krarup; H G Niesters; H Norder; J Georgsen
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

8.  Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.

Authors:  Jo Anne Chiavetta; Michael Escobar; Alice Newman; Yaohua He; Pete Driezen; Shelley Deeks; Devon E Hone; Sheila F O'Brien; Graham Sher
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

Review 9.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

Review 10.  Can routine neonatal circumcision help prevent human immunodeficiency virus transmission in the United States?

Authors:  Xiao Xu; Divya A Patel; Vanessa K Dalton; Mark D Pearlman; Timothy R B Johnson
Journal:  Am J Mens Health       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.